Clinical and pharmacokinetic evaluation of moxalactam in infants and children

Mathew Varghese, Abdul J. Khan, George Quaye, Urmila Patel, Kusum Kumar, Hugh Evans

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Moxalactam, a new beta-lactam antibiotic was evaluated in the treatment of 21 pediatric patients including 16 with clinical and radiological evidence of pneumonia and 5 with urinary tract infection (UTI). Clinical and radiological resolution of pneumonia occurred in all. Bacteriological efficacy in pneumonia, however, was assessed in only 1 patient whose blood culture grew H. influenzae type b. In patients with UTI, the therapy was successful, bacteriologically as well as clinically. The only side effects observed were mild transient elevation of SGOT and alkaline phosphatase in 6 cases. The peak and trough levels of the drug were manyfold higher than the known minimum inhibitory concentrations of common pathogens. The mean t½ projected of 95 and 124 min with intravenous and intramuscular route, respectively, were similar to those reported in adults.

Original languageEnglish (US)
Pages (from-to)417-420
Number of pages4
JournalChemotherapy
Volume28
Issue number6
DOIs
StatePublished - Jan 1 1982
Externally publishedYes

Fingerprint

Moxalactam
Pneumonia
Pharmacokinetics
Urinary Tract Infections
beta-Lactams
Microbial Sensitivity Tests
Aspartate Aminotransferases
Human Influenza
Alkaline Phosphatase
Pediatrics
Anti-Bacterial Agents
Therapeutics
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pharmacology
  • Drug Discovery
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Varghese, Mathew ; Khan, Abdul J. ; Quaye, George ; Patel, Urmila ; Kumar, Kusum ; Evans, Hugh. / Clinical and pharmacokinetic evaluation of moxalactam in infants and children. In: Chemotherapy. 1982 ; Vol. 28, No. 6. pp. 417-420.
@article{3969c11bf7b245ed8554dcba82632aba,
title = "Clinical and pharmacokinetic evaluation of moxalactam in infants and children",
abstract = "Moxalactam, a new beta-lactam antibiotic was evaluated in the treatment of 21 pediatric patients including 16 with clinical and radiological evidence of pneumonia and 5 with urinary tract infection (UTI). Clinical and radiological resolution of pneumonia occurred in all. Bacteriological efficacy in pneumonia, however, was assessed in only 1 patient whose blood culture grew H. influenzae type b. In patients with UTI, the therapy was successful, bacteriologically as well as clinically. The only side effects observed were mild transient elevation of SGOT and alkaline phosphatase in 6 cases. The peak and trough levels of the drug were manyfold higher than the known minimum inhibitory concentrations of common pathogens. The mean t½ projected of 95 and 124 min with intravenous and intramuscular route, respectively, were similar to those reported in adults.",
author = "Mathew Varghese and Khan, {Abdul J.} and George Quaye and Urmila Patel and Kusum Kumar and Hugh Evans",
year = "1982",
month = "1",
day = "1",
doi = "10.1159/000238132",
language = "English (US)",
volume = "28",
pages = "417--420",
journal = "Chemotherapy",
issn = "0009-3157",
publisher = "S. Karger AG",
number = "6",

}

Varghese, M, Khan, AJ, Quaye, G, Patel, U, Kumar, K & Evans, H 1982, 'Clinical and pharmacokinetic evaluation of moxalactam in infants and children', Chemotherapy, vol. 28, no. 6, pp. 417-420. https://doi.org/10.1159/000238132

Clinical and pharmacokinetic evaluation of moxalactam in infants and children. / Varghese, Mathew; Khan, Abdul J.; Quaye, George; Patel, Urmila; Kumar, Kusum; Evans, Hugh.

In: Chemotherapy, Vol. 28, No. 6, 01.01.1982, p. 417-420.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical and pharmacokinetic evaluation of moxalactam in infants and children

AU - Varghese, Mathew

AU - Khan, Abdul J.

AU - Quaye, George

AU - Patel, Urmila

AU - Kumar, Kusum

AU - Evans, Hugh

PY - 1982/1/1

Y1 - 1982/1/1

N2 - Moxalactam, a new beta-lactam antibiotic was evaluated in the treatment of 21 pediatric patients including 16 with clinical and radiological evidence of pneumonia and 5 with urinary tract infection (UTI). Clinical and radiological resolution of pneumonia occurred in all. Bacteriological efficacy in pneumonia, however, was assessed in only 1 patient whose blood culture grew H. influenzae type b. In patients with UTI, the therapy was successful, bacteriologically as well as clinically. The only side effects observed were mild transient elevation of SGOT and alkaline phosphatase in 6 cases. The peak and trough levels of the drug were manyfold higher than the known minimum inhibitory concentrations of common pathogens. The mean t½ projected of 95 and 124 min with intravenous and intramuscular route, respectively, were similar to those reported in adults.

AB - Moxalactam, a new beta-lactam antibiotic was evaluated in the treatment of 21 pediatric patients including 16 with clinical and radiological evidence of pneumonia and 5 with urinary tract infection (UTI). Clinical and radiological resolution of pneumonia occurred in all. Bacteriological efficacy in pneumonia, however, was assessed in only 1 patient whose blood culture grew H. influenzae type b. In patients with UTI, the therapy was successful, bacteriologically as well as clinically. The only side effects observed were mild transient elevation of SGOT and alkaline phosphatase in 6 cases. The peak and trough levels of the drug were manyfold higher than the known minimum inhibitory concentrations of common pathogens. The mean t½ projected of 95 and 124 min with intravenous and intramuscular route, respectively, were similar to those reported in adults.

UR - http://www.scopus.com/inward/record.url?scp=0020470601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020470601&partnerID=8YFLogxK

U2 - 10.1159/000238132

DO - 10.1159/000238132

M3 - Article

C2 - 6218971

AN - SCOPUS:0020470601

VL - 28

SP - 417

EP - 420

JO - Chemotherapy

JF - Chemotherapy

SN - 0009-3157

IS - 6

ER -